Monoclonal Antibodies The approach (s), which is/are currently followed to produce human monoclonal antibodies, is/are known as transformation of antigen specific B lymphocytes (EBV) combination of EB Vand hybridoma techniques hybridization of 6-thioguanine-resistant human plasmacytoma with immune human lymphocytes all of these transformation of antigen specific B lymphocytes (EBV) combination of EB Vand hybridoma techniques hybridization of 6-thioguanine-resistant human plasmacytoma with immune human lymphocytes all of these ANSWER DOWNLOAD EXAMIANS APP
Monoclonal Antibodies Some cross reactions with monoclonal antibodies (MAbs) can occur. Unexpected cross reactions occur more frequently with Ig MAbs IgE IgA IgG Ig MAbs IgE IgA IgG ANSWER DOWNLOAD EXAMIANS APP
Monoclonal Antibodies Preliminary clinical results with a humanized antibody against the interleukin-2 receptor have suggested the poor recognition of immunoglobulin, Ig constant regions presence of HAMA response All of these absence of human immune response against murine proteins (HAMA) response poor recognition of immunoglobulin, Ig constant regions presence of HAMA response All of these absence of human immune response against murine proteins (HAMA) response ANSWER DOWNLOAD EXAMIANS APP
Monoclonal Antibodies The cross linkage of antigens by antibodies is known as agglutination complement fixation all of these a cross reaction agglutination complement fixation all of these a cross reaction ANSWER DOWNLOAD EXAMIANS APP
Monoclonal Antibodies In monoclonal antibody technology, tumor cells that can replicate endlessly are fused with mammalian cells that produce an antibody. The result of this cell fusion is a lymphoblast hybridoma natural killer cell myeloma lymphoblast hybridoma natural killer cell myeloma ANSWER DOWNLOAD EXAMIANS APP